Cutler Group’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-17
| Closed | -$6K | – | 2326 |
|
2022
Q4 | $6K | Hold |
17
| – | – | ﹤0.01% | 1405 |
|
2022
Q3 | $5K | Sell |
17
-28
| -62% | -$8.24K | ﹤0.01% | 1572 |
|
2022
Q2 | $14K | Buy |
+45
| New | +$14K | ﹤0.01% | 1298 |
|
2022
Q1 | – | Sell |
-37
| Closed | -$16K | – | 2702 |
|
2021
Q4 | $16K | Sell |
37
-28
| -43% | -$12.1K | ﹤0.01% | 1547 |
|
2021
Q3 | $36K | Buy |
+65
| New | +$36K | ﹤0.01% | 1326 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 2833 |
|
2020
Q3 | – | Sell |
-83
| Closed | -$51K | – | 2371 |
|
2020
Q2 | $51K | Hold |
83
| – | – | ﹤0.01% | 842 |
|
2020
Q1 | $39K | Buy |
83
+66
| +388% | +$31K | ﹤0.01% | 832 |
|
2019
Q4 | $9K | Sell |
17
-19
| -53% | -$10.1K | ﹤0.01% | 1251 |
|
2019
Q3 | $23K | Sell |
36
-39
| -52% | -$24.9K | ﹤0.01% | 1023 |
|
2019
Q2 | $57K | Buy |
75
+50
| +200% | +$38K | 0.01% | 871 |
|
2019
Q1 | $17K | Buy |
25
+14
| +127% | +$9.52K | ﹤0.01% | 1091 |
|
2018
Q4 | $5K | Sell |
11
-11
| -50% | -$5K | ﹤0.01% | 1371 |
|
2018
Q3 | $19K | Buy |
22
+5
| +29% | +$4.32K | ﹤0.01% | 1182 |
|
2018
Q2 | $11K | Sell |
17
-77
| -82% | -$49.8K | ﹤0.01% | 1282 |
|
2018
Q1 | $42K | Buy |
94
+36
| +62% | +$16.1K | ﹤0.01% | 999 |
|
2017
Q4 | $25K | Sell |
58
-6
| -9% | -$2.59K | ﹤0.01% | 1329 |
|
2017
Q3 | $31K | Sell |
64
-396
| -86% | -$192K | ﹤0.01% | 1480 |
|
2017
Q2 | $255K | Sell |
460
-18
| -4% | -$9.98K | 0.01% | 760 |
|
2017
Q1 | $316K | Sell |
478
-223
| -32% | -$147K | 0.01% | 633 |
|
2016
Q4 | $234K | Buy |
701
+607
| +646% | +$203K | 0.01% | 787 |
|
2016
Q3 | $28K | Sell |
94
-28
| -23% | -$8.34K | ﹤0.01% | 1708 |
|
2016
Q2 | $21K | Sell |
122
-50
| -29% | -$8.61K | ﹤0.01% | 1803 |
|
2016
Q1 | $38K | Buy |
172
+103
| +149% | +$22.8K | ﹤0.01% | 1434 |
|
2015
Q4 | $42K | Buy |
+69
| New | +$42K | ﹤0.01% | 1501 |
|